We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
Stockal+Disclaimer.pdf
4 watching
Current Price
$223.63
$-7.32
(-3.17%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
7,680.79M
52-Week High
278.2532
52-Week Low
92.26
Average Volume
0.17M
Dividend Yield
--
P/E Ratio
--
Market Capitalization7,680.79M
52-Week High278.2532
52-Week Low92.26
Average Volume0.17M
Dividend Yield--
P/E Ratio--
What does the Stockal+Disclaimer.pdf do?
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, primarily focuses on developing novel therapies to address disabling neuropsychiatric conditions characterized by significant unmet medical needs. The company's lead product candidate is KarXT, an oral modulator that is in Phase II clinical trial for the treatment of acute psychosis in patients with schizophrenia, as well as in Phase Ib clinical trial for the treatment of central nervous system disorders, such as cognitive and negative symptoms, Alzheimer's, and pain. It also focuses on developing other muscarinic-targeted drug candidates. Karuna Pharmaceuticals, Inc. has a license agreement with Eli Lilly and Company; and patent license agreement with PureTech Health LLC. The company was formerly known as Karuna Pharmaceuticals, Inc. and changed its name to Karuna Therapeutics, Inc. in March 2019. Karuna Therapeutics, Inc. was founded in 2009 and is headquartered in Boston, Massachusetts. Karuna Therapeutics, Inc. operates as a subsidiary of PureTech Health plc.
Read More
How much money does Stockal+Disclaimer.pdf make?
News & Events about Stockal+Disclaimer.pdf.
Ticker Report
3days ago
Shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX Get Rating) have been assigned an average recommendation of Buy from the fifteen brokerages that are presently covering the stock, MarketBeat reports. Thirteen investment analysts have rated the stock with a buy rating. The ...
Zolmax
9days ago
Karuna Therapeutics, Inc. (NASDAQ:KRTX Get Rating) CFO Troy A. Ignelzi sold 16,500 shares of the businesss stock in a transaction that occurred on Tuesday, November 15th. The shares were sold at an average price of $225.85, for a total transaction of $3,726,525.00. Following the completion of the ...
Zolmax
16days ago
Karuna Therapeutics (NASDAQ:KRTX Get Rating) and IGM Biosciences (NASDAQ:IGMS Get Rating) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, risk, profitability and ...
Zolmax
23days ago
Karuna Therapeutics, Inc. (NASDAQ:KRTX Get Rating) COO Andrew Craig Miller sold 15,000 shares of the firms stock in a transaction on Tuesday, November 1st. The stock was sold at an average price of $225.08, for a total transaction of $3,376,200.00. Following the transaction, the chief operating ...
Business Wire
1month ago
PsychoGenics Inc. (PsychoGenics or the Company), a leader in AI-enabled phenotypic drug discovery and preclinical CRO services, today announced that clinical-stage biopharmaceutical company Karuna Therapeutics, Inc., (NASDAQ: KRTX) has extended its drug discovery collaboration with the Company...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
plus_minus_icon
Can Indians buy Stockal+Disclaimer.pdf shares?
plus_minus_icon
How can I buy Stockal+Disclaimer.pdf shares from India?
plus_minus_icon
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
plus_minus_icon
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
plus_minus_icon
What is today’s traded volume of Stockal+Disclaimer.pdf?
plus_minus_icon
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
plus_minus_icon
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
plus_minus_icon
Current Price
$223.63
$-7.32
(-3.17%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00